BioMe

Company Overview

Snapshot

Founded in November 2020 by Dana Cohen, Liora Madar Shapiro, and Tal Peleg-Shulman, BioMe operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its core technology.

Business overview

BioMe is a Health Tech & Life Sciences company specializing in personal microbiome processing, restoration, storage, and analytics. The company's core technology involves safe, dry, and odor-free microbiome capsules designed for healthy adults. These self-microbiome capsules aim to accelerate the natural restoration of gut microbiota often impacted by medications such as antibiotics, antidepressants, laxatives, and chemotherapy. BioMe operates within the Pharmaceuticals sector, targeting markets in North America and Asia with a B2B business model.

Company Intelligence Q&A

What is BioMe's primary focus?

BioMe focuses on personal microbiome processing, restoration, storage, and analytics, developing solutions to accelerate the natural restoration of gut microbiota.

When was BioMe founded and by whom?

BioMe was founded in November 2020 by Dana Cohen, Liora Madar Shapiro, and Tal Peleg-Shulman.

What is the current employee size of BioMe?

BioMe currently has 1–10 employees.

What markets does BioMe target?

BioMe targets geomarkets in North America and Asia.

What is BioMe's product development stage?

BioMe's products are currently in the R&D stage, focusing on developing its core technology for personal microbiome processing, restoration, storage, and analytics.